Welcome to the new Gustave Roussy website
A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.
Gustave Roussy Prize : A New Award for Innovation in Oncology
The Institute is launching the Gustave Roussy Prize to mark the 150th anniversary of the birth of its visionary founder.
Published on
Changed on
The Institute is launching the Gustave Roussy Prize to mark the 150th anniversary of the birth of its visionary founder. With an endowment of €200,000, this scientific award will annually recognize a researcher whose discoveries in the fight against cancer have a major impact on patient care.
Born 150 years ago, Professor Gustave Roussy permanently transformed oncology by establishing the first consultation entirely dedicated to cancer patients in 1921. With the launch of the Gustave Roussy Prize, the Institute pays tribute to his legacy by annually honoring a leading global figure in oncology whose discoveries improve cancer patient care, as well as contribute to a better understanding and prevention of the disease.
Applications must be submitted by December 20, 2024
For this inaugural edition of the Gustave Roussy Prize, applications must be submitted no later than December 20, 2024, via the following link: https://forms.office.com/e/rBSaqphxwG.
The jury, composed of international experts independent of Gustave Roussy, will evaluate submissions based on the impact of the discoveries and their direct benefits for patients.
The award ceremony will take place on February 4, 2025, coinciding with World Cancer Day.
The Gustave Roussy Prize is supported by Pierre Fabre Laboratories as founding sponsor.
Submit your application here: https://forms.office.com/e/rBSaqphxwG
Last news
-
Breast Cancer: Gustave Roussy Ranked No. 1 in France for Breast Surgery and Breast Reconstruction
On the occasion of Breast Cancer Awareness Month, the 2025 data from Visuchir, the national surgical activity monitoring tool of the French Health Insurance system, places Gustave Roussy in first position for both breast surgery and breast reconstruction. Beyond this ranking, these figures highlight that reconstruction is now an integral part of breast cancer treatment. It is considered at every stage of care: from tumor removal surgery, whether lumpectomy or mastectomy, through to the post-cancer period, helping to restore the body and support women in regaining their physical integrity and quality of life.
-
Newsweek Ranking: Gustave Roussy Named Europe’s Leading Cancer Centre and Third Best Worldwide
The 2027 edition of Newsweek’s World's Best Specialized Hospitals ranking once again recognises Gustave Roussy as the leading cancer centre in France and Europe, and the third best worldwide. This distinction highlights the excellence of the Institute’s care and research, as well as the daily commitment of all its professionals.
-
Living with and beyond cancer: the promises and challenges of digital health
In a Viewpoint article published in The Lancet Digital Health, Drs Ines Vaz-Luis and Maria Alice Franzoi, together with Emmanuel Mussault, a patient partner at the PRISM University Hospital Institute, examine the role that digital tools can play in supporting people living with and beyond cancer. Their central message is that these technologies can support more personalised and accessible care, but their value depends primarily on how they are integrated into care pathways, the human support provided, their ability to address individual needs and their evaluation in real-world settings.
-
Gustave Roussy and The Lancet launch an international lecture series on innovations transforming cancer care
The inaugural lecture in the “Lecture Series on Cancer Breakthroughs” will take place on Friday 18 September at 5:00 pm. It will be delivered by Professor Timothy R. Rebbeck, a leading cancer prevention specialist at Harvard University and the Dana-Farber Cancer Institute.
